Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009

Clinical Infectious Diseases

Volumn 56, Issue 1, 2013, Pages 11-19

  Phillips, Christopher J ^a   Woolpert, Tabitha ^a   Sevick, Carter ^a   Faix, Dennis ^a   Blair, Patrick J ^a   Crum Cianflone, Nancy F ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

attenuated influenza vaccine; influenza like illness; military; pneumonia; trivalent inactivated influenza vaccine

Indexed keywords

INFLUENZA VACCINE; TRIVALENT INACTIVATED INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; GEOGRAPHY; HUMAN; INFLUENZA; INFLUENZA LIKE ILLNESS; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; OCCUPATION; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASON; SOCIOECONOMICS; UNITED STATES;

EID: 84871254889     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis860     Document Type: Article

References (32)

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
3. Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008; 26:911-24.
4. Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 1999; 5:379-85.
5. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010; 7:CD001269.
6. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
7. Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25:870-79.
8. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-6.
9. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25:860-9.
10. Ambrose CS, Wu X, Knuf M, Wutzler P. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine 2012; 30:886-92.
11. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007; 120:e553-64.
12. Halloran ME, Piedra PA, Longini IM Jr, et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 2007; 25:4038-45.
13. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22.
14. Ohmit SE, Victor JC, Teich ER, et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008; 198:312-7.
15. Eick AA, Wang Z, Hughes H, Ford SM, Tobler SK. Comparison of the trivalent live attenuated vs inactivated influenza vaccines among U.S. military service members. Vaccine 2009; 27:3568-75.
16. Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361:1260-7.
17. Wang Z, Tobler S, Roayaei J, Eick A. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 2009; 301:945-53.
18. Treanor JJ, Kotloff K, Betts RF, et al. Evaluation of trivalent, live, coldadapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999; 18:899-906.
19. Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Vaccine 2011; 29:3633-9.
20. Ryan MA, Smith TC, Smith B, et al. Millennium Cohort: enrollment begins a 21-year contribution to understanding the impact of military service. J Clin Epidemiol 2007; 60:181-91.
21. Novel Swine-Origin Influenza A (H1N1) Virus Investigation TeamDawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-15.
22. Centers for Disease Control and Prevention. 2008-2009 influenza season week 12 ending March 28, 2009. FluView, 2009. Available at: http://www.cdc.gov/ flu/weekly/weeklyarchives2008-2009/weekly12. htm. Accessed 1 August 2011.
23. Marsden-Haug N, Foster VB, Gould PL, Elbert E, Wang H, Pavlin JA. Code-based syndromic surveillance for influenza like illness by International Classification of Diseases, 9th revision. Emerg Infect Dis 2007; 13:207-16.
24. Centers for Disease Control and Prevention. Update: influenza activity-United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine. MMWR Morb Mortal Wkly Rep 2007; 56:789-94.
25. Centers for Disease Control and Prevention. Update: influenza activity-United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep 2008; 57:692-7.
26. Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a selfreport version of PRIME-MD. The PHQ Primary Care Study. JAMA 1999; 282:1737-44.
27. Ambrose CS, Levin MJ, Belshe RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza and Other Respiratory Viruses 2011; 5:67-75.
28. Guidance for the use of influenza vaccine for the 2011-2012 influenza season. Available at: http://www.vaccines.mil/documents/1456HA% 20Guidance%20for%202011-2012%20Influenza%20Season.pdf. Accessed 21 October 2011.
29. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004; 59:1-15.
30. Hoft DF, Babusis E, Worku S, et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011; 204:845-53.
31. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96.
32. Dill CE, Favata MA. Novel influenza A (H1N1) outbreak on board a US Navy vessel. Disaster Medicine and Public Health Preparedness 2009; 3:S117-20.